Funds and ETFs Dishman Carbogen Amcis Limited

Equities

DCAL

INE385W01011

Pharmaceuticals

Market Closed - NSE India S.E. 07:43:51 2024-05-22 EDT 5-day change 1st Jan Change
192.2 INR -1.44% Intraday chart for Dishman Carbogen Amcis Limited -0.75% +12.40%

ETFs positioned on Dishman Carbogen Amcis Limited

Name Weight AuM 1st Jan change Investor Rating
0.00% 112 M€ +4.91% -
Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS), quats, specialty chemicals, Vitamins D3 and its analogues, cholesterols, and disinfectants. The Company’s segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. Its Marketable Molecules segment manufactures and supplies intermediates, chemicals, and various products for pharmaceutical, cosmetic and related industries. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd. and Dishman Carbogen Amcis (Singapore) Pte. Ltd.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DCAL Stock
  4. Funds and ETFs Dishman Carbogen Amcis Limited